Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bunker

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Journal of Psychiatric Research|June 25, 2024
Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2)Harold A Sackeim, Scott T Aaronson, Mark T Bunker, et al.
Psychological Medicine|January 5, 2023
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of lifeHarold A Sackeim, A John Rush, Teresa Greco, et al.
The Australian and New Zealand Journal of Psychiatry|November 6, 2023
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effectsScott T Aaronson, Harold A Sackeim, Mei Jiang, et al.
Psychological Medicine|January 7, 2022
Clinical research challenges posed by difficult-to-treat depressionA John Rush, Harold A Sackeim, Charles R Conway, et al.
Journal of Mood and Anxiety Disorders|July 14, 2025
An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depressionCharles R Conway, A John Rush, Charles Gordon, et al.
The Journal of Clinical Psychiatry|July 17, 2025
Prognostic and Prescriptive Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial ReportScott T Aaronson, Charles R Conway, Charles Gordon, et al.
Journal of Affective Disorders|December 26, 2024
Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial reportVictoria C de Leon, Rebecca M Allen, João Quevedo, et al.
Brain Stimulation|April 4, 2024
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial reportCharles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
Brain Stimulation|December 19, 2024
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trialA John Rush, Charles R Conway, Scott T Aaronson, et al.
Brain Stimulation|December 20, 2024
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trialCharles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Psychiatric Research|June 25, 2024
Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2)Harold A Sackeim, Scott T Aaronson, Mark T Bunker, et al.
Psychological Medicine|January 5, 2023
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of lifeHarold A Sackeim, A John Rush, Teresa Greco, et al.
The Australian and New Zealand Journal of Psychiatry|November 6, 2023
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effectsScott T Aaronson, Harold A Sackeim, Mei Jiang, et al.
Psychological Medicine|January 7, 2022
Clinical research challenges posed by difficult-to-treat depressionA John Rush, Harold A Sackeim, Charles R Conway, et al.
Journal of Mood and Anxiety Disorders|July 14, 2025
An examination of symptoms, function and quality of life as conjoint clinical outcome domains for treatment-resistant depressionCharles R Conway, A John Rush, Charles Gordon, et al.
The Journal of Clinical Psychiatry|July 17, 2025
Prognostic and Prescriptive Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial ReportScott T Aaronson, Charles R Conway, Charles Gordon, et al.
Journal of Affective Disorders|December 26, 2024
Suicide characteristics in patients with marked treatment-resistant major depressive disorder: A RECOVER trial reportVictoria C de Leon, Rebecca M Allen, João Quevedo, et al.
Brain Stimulation|April 4, 2024
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial reportCharles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
Brain Stimulation|December 19, 2024
Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trialA John Rush, Charles R Conway, Scott T Aaronson, et al.
Brain Stimulation|December 20, 2024
Vagus nerve stimulation in treatment-resistant depression: A one-year, randomized, sham-controlled trialCharles R Conway, Scott T Aaronson, Harold A Sackeim, et al.
Pageof 4